Cargando…

Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA

Conventional chemotherapy is plagued with adverse side effects because cancer treatments are subject to numerous variations, most predominantly from drug resistance. Accordingly, multiple or multistage chemotherapeutic regimens are often performed, combining two or more drugs with orthogonal and pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Hong Yeol, Son, Sejin, Lee, So Jin, You, Dong Gil, Yhee, Ji Young, Park, Jae Hyung, Swierczewska, Maggie, Lee, Seulki, Kwon, Ick Chan, Kim, Sun Hwa, Kim, Kwangmeyung, Pomper, Martin G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217108/ https://www.ncbi.nlm.nih.gov/pubmed/25363213 http://dx.doi.org/10.1038/srep06878

Ejemplares similares

Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics
por: Min, Hyun Su, et al.
Publicado: (2015)

In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity
por: Chang, Hyeyoun, et al.
Publicado: (2023)

Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound
por: Choi, Yongwhan, et al.
Publicado: (2020)

The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts
por: Yhee, Ji Young, et al.
Publicado: (2017)

Tumor-Targeting Glycol Chitosan Nanoparticles for Image-Guided Surgery of Rabbit Orthotopic VX2 Lung Cancer
por: On, Kyeong Cheol, et al.
Publicado: (2020)

ROS-generating TiO(2) nanoparticles for non-invasive sonodynamic therapy of cancer
por: You, Dong Gil, et al.
Publicado: (2016)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
por: Song, Sukyung, et al.
Publicado: (2023)

Antitumor therapeutic application of self-assembled RNAi-AuNP nanoconstructs: Combination of VEGF-RNAi and photothermal ablation
por: Son, Sejin, et al.
Publicado: (2017)

Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system
por: Oh, Keun Sang, et al.
Publicado: (2014)

In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles
por: Jeong, Eun-Ju, et al.
Publicado: (2021)

Photoacoustic imaging of cancer cells with glycol-chitosan-coated gold nanoparticles as contrast agents
por: Sun, In-Cheol, et al.
Publicado: (2019)

Iodinated Echogenic Glycol Chitosan Nanoparticles for X-ray CT/US Dual Imaging of Tumor
por: Choi, Daeil, et al.
Publicado: (2018)

Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
por: Park, Jiwon, et al.
Publicado: (2023)

Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging
por: Key, Jaehong, et al.
Publicado: (2016)

Thiol-Responsive Gold Nanodot Swarm with Glycol Chitosan for Photothermal Cancer Therapy
por: Jo, SeongHoon, et al.
Publicado: (2021)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
por: Choi, Yongwhan, et al.
Publicado: (2020)

Protease Activity: Meeting Its Theranostic Potential
por: Lee, Seulki, et al.
Publicado: (2012)

Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019)

Theragnostic Glycol Chitosan-Conjugated Gold Nanoparticles for Photoacoustic Imaging of Regional Lymph Nodes and Delivering Tumor Antigen to Lymph Nodes
por: Sun, In-Cheol, et al.
Publicado: (2021)

Real-Time Video Imaging of Protease Expression In Vivo
por: Zhu, Lei, et al.
Publicado: (2011)

Design of a Multicomponent Peptide-Woven Nanocomplex for Delivery of siRNA
por: Jun, Eunsung, et al.
Publicado: (2015)

Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound
por: You, Dong Gil, et al.
Publicado: (2017)

Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy
por: Ciofani, Gianni, et al.
Publicado: (2010)

Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs
por: Kanwal, Ummarah, et al.
Publicado: (2018)

Assessment of Collagen-Induced Arthritis Using Cyanine 5.5 Conjugated with Hydrophobically Modified Glycol Chitosan Nanoparticles: Correlation with (18)F-Fluorodeoxyglucose Positron Emission Tomography Data
por: Cha, Ji Hyeon, et al.
Publicado: (2012)

Inhibition of cell proliferation through an ATP-responsive co-delivery system of doxorubicin and Bcl-2 siRNA
por: Zhang, Jianxu, et al.
Publicado: (2017)

Optical Imaging of Cancer-Related Proteases Using Near-Infrared Fluorescence Matrix Metalloproteinase-Sensitive and Cathepsin B-Sensitive Probes
por: Yhee, Ji Young, et al.
Publicado: (2012)

Stimuli-Responsive Drug Delivery of Doxorubicin Using Magnetic Nanoparticle Conjugated Poly(ethylene glycol)-g-Chitosan Copolymer
por: Yoon, Hyun-Min, et al.
Publicado: (2021)

Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin
por: Yu, Jingmou, et al.
Publicado: (2012)

A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin⋅hydrochloride for thyroid cancer treatment in vitro and in vivo
por: Yoo, Youngbum, et al.
Publicado: (2018)

Molecular interaction mechanisms of glycol chitosan self-healing hydrogel as a drug delivery system for gemcitabine and doxorubicin
por: Huang, Tzu-Hsuan, et al.
Publicado: (2022)

Protease-Activated Drug Development
por: Choi, Ki Young, et al.
Publicado: (2012)

Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance
por: Li, Yinghuan, et al.
Publicado: (2020)

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake
por: Fesler, Andrew, et al.
Publicado: (2022)

Engineered Zn(II)-Dipicolylamine-Gold Nanorod Provides Effective Prostate Cancer Treatment by Combining siRNA Delivery and Photothermal Therapy
por: Min, Kyung Hyun, et al.
Publicado: (2017)

Preliminary Study of Conformation and Drug Release Mechanism of Doxorubicin-Conjugated Glycol Chitosan, via cis-Aconityl Linkage, by Molecular Modeling
por: Srinophakun, Thongchai, et al.
Publicado: (2011)

Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications
por: Chai, Fujuan, et al.
Publicado: (2017)

Chitosan Combined with Poly-L-arginine as Efficient, Safe, and Serum-Insensitive Vehicle with RNase Protection Ability for siRNA Delivery
por: Plianwong, Samarwadee, et al.
Publicado: (2013)

Microporous methacrylated glycol chitosan-montmorillonite nanocomposite hydrogel for bone tissue engineering
por: Cui, Zhong-Kai, et al.
Publicado: (2019)

A Novel Chitosan Nanosponge as a Vehicle for Transepidermal Drug Delivery
por: Lee, Jin Sil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6rhovnhur2fg4tk5746471h60i